Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
The molecular features that define clear cell renal cell carcinoma (ccRCC) initiation and
progression are being increasingly defined. The TRACERx Renal studies and others that …
progression are being increasingly defined. The TRACERx Renal studies and others that …
Pancreatic cancer biology and genetics from an evolutionary perspective
A Makohon-Moore, CA Iacobuzio-Donahue - Nature Reviews Cancer, 2016 - nature.com
Cancer is an evolutionary disease, containing the hallmarks of an asexually reproducing
unicellular organism subject to evolutionary paradigms. Pancreatic ductal adenocarcinoma …
unicellular organism subject to evolutionary paradigms. Pancreatic ductal adenocarcinoma …
Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Mutational signature analysis is commonly performed in cancer genomic studies. Here, we
present SigProfilerExtractor, an automated tool for de novo extraction of mutational …
present SigProfilerExtractor, an automated tool for de novo extraction of mutational …
Genomic analyses identify molecular subtypes of pancreatic cancer
Integrated genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32
recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-β, WNT, NOTCH …
recurrently mutated genes that aggregate into 10 pathways: KRAS, TGF-β, WNT, NOTCH …
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras… - Nature, 2012 - nature.com
Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed
exome sequencing and copy number analysis to define genomic aberrations in a …
exome sequencing and copy number analysis to define genomic aberrations in a …
VHL, the story of a tumour suppressor gene
L Gossage, T Eisen, ER Maher - Nature Reviews Cancer, 2015 - nature.com
Abstract Since the Von Hippel–Lindau (VHL) disease tumour suppressor gene VHL was
identified in 1993 as the genetic basis for a rare disorder, it has proved to be of wide medical …
identified in 1993 as the genetic basis for a rare disorder, it has proved to be of wide medical …
Genetic and epigenetic basis of hepatoblastoma diversity
Hepatoblastoma (HB) is the most common pediatric liver malignancy; however, hereditary
predisposition and acquired molecular aberrations related to HB clinicopathological …
predisposition and acquired molecular aberrations related to HB clinicopathological …
Pancreatic cancer
Pancreatic cancer is a major cause of cancer-associated mortality, with a dismal overall
prognosis that has remained virtually unchanged for many decades. Currently, prevention or …
prognosis that has remained virtually unchanged for many decades. Currently, prevention or …
Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment
K Katsushima, A Natsume, F Ohka, K Shinjo… - Nature …, 2016 - nature.com
Targeting self-renewal is an important goal in cancer therapy and recent studies have
focused on Notch signalling in the maintenance of stemness of glioma stem cells (GSCs) …
focused on Notch signalling in the maintenance of stemness of glioma stem cells (GSCs) …
The spectrum of SWI/SNF mutations, ubiquitous in human cancers
AH Shain, JR Pollack - PloS one, 2013 - journals.plos.org
SWI/SNF is a multi-subunit chromatin remodeling complex that uses the energy of ATP
hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating …
hydrolysis to reposition nucleosomes, thereby modulating gene expression. Accumulating …